379 related articles for article (PubMed ID: 19422003)
1. Design and synthesis of Trypanosoma brucei active 1-alkyloxy and 1-benzyloxyadamantano 2-guanylhydrazones.
Papanastasiou I; Tsotinis A; Zoidis G; Kolocouris N; Prathalingam SR; Kelly JM
ChemMedChem; 2009 Jul; 4(7):1059-62. PubMed ID: 19422003
[TBL] [Abstract][Full Text] [Related]
2. Studies toward the structural optimization of new brazilizone-related trypanocidal 1,3,4-thiadiazole-2-arylhydrazone derivatives.
Carvalho SA; Lopes FA; Salomão K; Romeiro NC; Wardell SM; de Castro SL; da Silva EF; Fraga CA
Bioorg Med Chem; 2008 Jan; 16(1):413-21. PubMed ID: 17904851
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitrypanosomal profile of new functionalized 1,3,4-thiadiazole-2-arylhydrazone derivatives, designed as non-mutagenic megazol analogues.
Carvalho SA; da Silva EF; Santa-Rita RM; de Castro SL; Fraga CA
Bioorg Med Chem Lett; 2004 Dec; 14(24):5967-70. PubMed ID: 15546709
[TBL] [Abstract][Full Text] [Related]
4. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of a series of melamine-based nitroheterocycles with activity against Trypanosomatid parasites.
Baliani A; Bueno GJ; Stewart ML; Yardley V; Brun R; Barrett MP; Gilbert IH
J Med Chem; 2005 Aug; 48(17):5570-9. PubMed ID: 16107157
[TBL] [Abstract][Full Text] [Related]
6. In vitro antitrypanosomal activity of 12 low-molecular-weight antibiotics and observations of structure/activity relationships.
Iwatsuki M; Otoguro K; Ishiyama A; Namatame M; Nishihara-Tukashima A; Hashida J; Nakashima T; Masuma R; Takahashi Y; Yamada H; Omura S
J Antibiot (Tokyo); 2010 Oct; 63(10):619-22. PubMed ID: 20717119
[No Abstract] [Full Text] [Related]
7. Design, synthesis, and structure-activity relationship of Trypanosoma brucei leucyl-tRNA synthetase inhibitors as antitrypanosomal agents.
Ding D; Meng Q; Gao G; Zhao Y; Wang Q; Nare B; Jacobs R; Rock F; Alley MR; Plattner JJ; Chen G; Li D; Zhou H
J Med Chem; 2011 Mar; 54(5):1276-87. PubMed ID: 21322634
[TBL] [Abstract][Full Text] [Related]
8. Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents.
Qiao Z; Wang Q; Zhang F; Wang Z; Bowling T; Nare B; Jacobs RT; Zhang J; Ding D; Liu Y; Zhou H
J Med Chem; 2012 Apr; 55(7):3553-7. PubMed ID: 22360533
[TBL] [Abstract][Full Text] [Related]
9. Discovery of halo-nitrobenzamides with potential application against human African trypanosomiasis.
Hwang JY; Smithson D; Connelly M; Maier J; Zhu F; Guy KR
Bioorg Med Chem Lett; 2010 Jan; 20(1):149-52. PubMed ID: 19963377
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of oxysterols and nitrogenous sterols with antileishmanial and trypanocidal activities.
Bazin MA; Loiseau PM; Bories C; Letourneux Y; Rault S; El Kihel L
Eur J Med Chem; 2006 Oct; 41(10):1109-16. PubMed ID: 16949702
[TBL] [Abstract][Full Text] [Related]
11. Stereospecific synthesis of chiral 2,3-dihydro-1,4-benzodithiine and methyl-2,3-dihydro-1,4-benzodithiine derivatives and their toxic effects on Trypanosoma brucei.
Ali Shah ST; Merkel P; Ragge H; Duszenko M; Rademann J; Voelter W
Chembiochem; 2005 Aug; 6(8):1438-41. PubMed ID: 16052614
[TBL] [Abstract][Full Text] [Related]
12. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO
Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agents.
Ohkanda J; Buckner FS; Lockman JW; Yokoyama K; Carrico D; Eastman R; de Luca-Fradley K; Davies W; Croft SL; Van Voorhis WC; Gelb MH; Sebti SM; Hamilton AD
J Med Chem; 2004 Jan; 47(2):432-45. PubMed ID: 14711313
[TBL] [Abstract][Full Text] [Related]
15. Promising lead compounds for novel antiprotozoals.
Otoguro K; Iwatsuki M; Ishiyama A; Namatame M; Nishihara-Tukashima A; Shibahara S; Kondo S; Yamada H; Omura S
J Antibiot (Tokyo); 2010 Jul; 63(7):381-4. PubMed ID: 20661239
[No Abstract] [Full Text] [Related]
16. Synthesis and biological evaluation of 1,4-benzodiazepin-2-ones with antitrypanosomal activity.
Spencer J; Rathnam RP; Harvey AL; Clements CJ; Clark RL; Barrett MP; Wong PE; Male L; Coles SJ; Mackay SP
Bioorg Med Chem; 2011 Mar; 19(5):1802-15. PubMed ID: 21306904
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and trypanocidal activity of new aminoadamantane derivatives.
Papanastasiou I; Tsotinis A; Kolocouris N; Prathalingam SR; Kelly JM
J Med Chem; 2008 Mar; 51(5):1496-500. PubMed ID: 18281929
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi.
Greenbaum DC; Mackey Z; Hansell E; Doyle P; Gut J; Caffrey CR; Lehrman J; Rosenthal PJ; McKerrow JH; Chibale K
J Med Chem; 2004 Jun; 47(12):3212-9. PubMed ID: 15163200
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of bioactive 1,2-annulated adamantane derivatives.
Zoidis G; Tsotinis A; Kolocouris N; Kelly JM; Prathalingam SR; Naesens L; De Clercq E
Org Biomol Chem; 2008 Sep; 6(17):3177-85. PubMed ID: 18698478
[TBL] [Abstract][Full Text] [Related]
20. Antitrypanosomal naphthylisoquinoline alkaloids and related compounds.
Bringmann G; Hoerr V; Holzgrabe U; Stich A
Pharmazie; 2003 May; 58(5):343-6. PubMed ID: 12779053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
